Devrim Çabuk

745 total citations
37 papers, 191 citations indexed

About

Devrim Çabuk is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Devrim Çabuk has authored 37 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Devrim Çabuk's work include Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Devrim Çabuk is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Devrim Çabuk collaborates with scholars based in Türkiye, United States and United Kingdom. Devrim Çabuk's co-authors include Kazım Uygun, Umut Kefeli, Faysal Dane, Hasan Şenol Çoşkun, Nazım Serdar Turhal, Tayfun Şahı̇n, Atalay Doğru, Perran Fulden Yumuk, Bülent Karabulut and Mehmet Artaç and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Devrim Çabuk

32 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devrim Çabuk Türkiye 9 79 49 45 37 28 37 191
Sherry Shen United States 10 111 1.4× 95 1.9× 50 1.1× 35 0.9× 50 1.8× 33 266
Beibei Mao China 8 86 1.1× 63 1.3× 55 1.2× 43 1.2× 9 0.3× 25 202
Songfeng Zhao China 8 49 0.6× 100 2.0× 53 1.2× 70 1.9× 26 0.9× 18 255
Lorenz Buser Switzerland 8 52 0.7× 84 1.7× 24 0.5× 29 0.8× 33 1.2× 14 200
Puneet Singh Australia 9 124 1.6× 94 1.9× 52 1.2× 78 2.1× 20 0.7× 15 263
Anna Linder Sweden 10 57 0.7× 69 1.4× 63 1.4× 53 1.4× 6 0.2× 19 214
Rebeca Alba Rubío Germany 6 67 0.8× 70 1.4× 49 1.1× 20 0.5× 13 0.5× 10 160
Hersh Gupta United States 6 89 1.1× 87 1.8× 31 0.7× 16 0.4× 11 0.4× 12 262
Peter Saliba‐Gustafsson Sweden 7 64 0.8× 55 1.1× 23 0.5× 40 1.1× 32 1.1× 14 202
Delia I. Fernández Netherlands 8 28 0.4× 45 0.9× 34 0.8× 16 0.4× 46 1.6× 14 232

Countries citing papers authored by Devrim Çabuk

Since Specialization
Citations

This map shows the geographic impact of Devrim Çabuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devrim Çabuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devrim Çabuk more than expected).

Fields of papers citing papers by Devrim Çabuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devrim Çabuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devrim Çabuk. The network helps show where Devrim Çabuk may publish in the future.

Co-authorship network of co-authors of Devrim Çabuk

This figure shows the co-authorship network connecting the top 25 collaborators of Devrim Çabuk. A scholar is included among the top collaborators of Devrim Çabuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devrim Çabuk. Devrim Çabuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Çabuk, Devrim, et al.. (2024). Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review). Oncology Letters. 27(4). 145–145. 3 indexed citations
4.
5.
6.
Kefeli, Umut, et al.. (2021). Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey. Supportive Care in Cancer. 29(12). 7497–7503. 7 indexed citations
7.
Savlı, Hakan, et al.. (2019). TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing. Journal of Biotechnology. 300. 87–93. 17 indexed citations
8.
Çabuk, Devrim, et al.. (2019). Gastrointestinal Involvement in a Patient with Chronic Lymphocytic Leukemia. Balkan Medical Journal. 37(1). 50–51. 1 indexed citations
9.
Korkmaz, Levent, Hasan Şenol Çoşkun, Faysal Dane, et al.. (2018). Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study. Surgical Oncology. 27(3). 485–489. 6 indexed citations
10.
Artaç, Mehmet, Levent Korkmaz, Hasan Şenol Çoşkun, et al.. (2018). Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients. Journal of Gastrointestinal Cancer. 50(2). 214–220. 16 indexed citations
11.
Çabuk, Devrim, Turgay Şimşek, Gülçin Gacar, et al.. (2017). The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.. PubMed. 21(5). 1121–1128. 6 indexed citations
12.
Erdoğan, Bülent, Senem Karabulut, Hilmi Tozkır, et al.. (2016). Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation. Bosnian Journal of Basic Medical Sciences. 16(4). 280–285. 3 indexed citations
13.
Artaç, Mehmet, Hasan Şenol Çoşkun, Faysal Dane, et al.. (2016). Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study. Journal of Gastrointestinal Cancer. 47(3). 264–272. 1 indexed citations
14.
15.
Çabuk, Devrim, Gül Başaran, Faysal Dane, et al.. (2014). Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience. Asian Pacific Journal of Cancer Prevention. 15(1). 117–122. 10 indexed citations
16.
Beneklı, Mustafa, Metin Özkan, Emin Tamer Elkıran, et al.. (2014). Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population. OncoTargets and Therapy. 8. 1–1. 12 indexed citations
17.
Başaran, Gül, et al.. (2014). Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.. PubMed. 7(5). 1459–64. 1 indexed citations
18.
Çabuk, Devrim, et al.. (2014). Primary Synovial Sarcoma of Lung. The Korean Journal of Thoracic and Cardiovascular Surgery. 47(3). 306–309. 11 indexed citations
19.
Uygun, Kazım, Ahmet Bılıcı, Serap Kaya, et al.. (2013). Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions. Asian Pacific Journal of Cancer Prevention. 14(4). 2283–2288. 12 indexed citations
20.
Doğru, Atalay, et al.. (2013). Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with Anthracyclines. Onkologie. 36(12). 712–716. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherry Shen Breakdown of academic impact, for papers by Beibei Mao Breakdown of academic impact, for papers by Songfeng Zhao Breakdown of academic impact, for papers by Lorenz Buser Breakdown of academic impact, for papers by Puneet Singh Breakdown of academic impact, for papers by Anna Linder Breakdown of academic impact, for papers by Rebeca Alba Rubío Breakdown of academic impact, for papers by Hersh Gupta Breakdown of academic impact, for papers by Peter Saliba‐Gustafsson Breakdown of academic impact, for papers by Delia I. Fernández
Rankless by CCL
2026